T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis
T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis have?
T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis has 84 citations in the OpenAlex counts ScholarIQ stores.
When was T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis published?
T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis has 2008 year in the ScholarIQ index.
What is the open-access status of T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis?
T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis has gold oa status in the ScholarIQ index.
What is the DOI of T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis?
The DOI for T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis is on the source record.
What is the PMID of T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis?
The PMID for T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis is on the source record.
What is the OpenAlex record for T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis?
The OpenAlex for T-614, a novel immunomodulator, attenuates joint inflammation and articular damage in collagen-induced arthritis is on the source record.